Fennec Pharmaceuticals
FENC
32 hedge funds and large institutions have $110M invested in Fennec Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 10 closing their positions.
25% more capital invested
Capital invested by funds: $88M → $110M (+$21.7M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.67% less ownership
Funds ownership: 46.46% → 44.79% (-1.7%)
18% less funds holding
Funds holding: 39 → 32 (-7)
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
68% less call options, than puts
Call options by funds: $157K | Put options by funds: $494K
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HFA
Harbert Fund Advisors
Birmingham,
Alabama
|
+$404K |
| 2 |
DCM
DG Capital Management
New York
|
+$223K |
| 3 |
Belvedere Trading
Chicago,
Illinois
|
+$133K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$94.1K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$45K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.1M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$607K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$501K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$442K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$338K |
FENC Hedge Fund Activity: Q3 2021 in Review
32 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q3 2021, worth a combined $110M — up 25% from $88M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of FENC and 3 opened new positions — a net loss of 7 holders — while 13 trimmed existing stakes and 6 added.
The largest buyer was Harbert Fund Advisors, adding an estimated $404K. The largest seller was Millennium Management, cutting an estimated $1.1M.
- 32 institutional investors held Fennec Pharmaceuticals (FENC) as of Q3 2021, down from 39 in Q2 2021.
- Funds reported $110M of Fennec Pharmaceuticals stock for Q3 2021, up 25% quarter-over-quarter.
- 3 funds opened new Fennec Pharmaceuticals positions in Q3 2021 and 10 closed out, a net change of -7 holders.
- The largest Fennec Pharmaceuticals buyer in Q3 2021 was Harbert Fund Advisors, an estimated $404K added.
- The largest Fennec Pharmaceuticals seller in Q3 2021 was Millennium Management, an estimated $1.1M sold.
Based on aggregated 13F filings for Q3 2021.